Ginkgo Bioworks Holdings Inc Earnings

Ginkgo Bioworks Holdings Inc’s revenue jumped 60.65% since last year same period to $89.05Mn in the Q3 2024. On a quarterly growth basis, Ginkgo Bioworks Holdings Inc has generated 58.43% jump in its revenue since last 3-months.

Ginkgo Bioworks Holdings Inc’s net profit jumped 81.38% since last year same period to $-56.4Mn in the Q3 2024. On a quarterly growth basis, Ginkgo Bioworks Holdings Inc has generated 74.03% jump in its net profits since last 3-months.

Ginkgo Bioworks Holdings Inc’s net profit margin jumped 88.41% since last year same period to -63.34% in the Q3 2024. On a quarterly growth basis, Ginkgo Bioworks Holdings Inc has generated 83.61% jump in its net profit margins since last 3-months.

Ginkgo Bioworks Holdings Inc’s earning per share (EPS) estimates for the current year stand at -0.08.

Ginkgo Bioworks Holdings Inc’s earning per share (EPS) fell -575% since last year same period to -1.08 in the Q3 2024. This indicates that the Ginkgo Bioworks Holdings Inc has generated -575% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Ginkgo Bioworks Holdings Inc’s return on assets (ROA) stands at -0.21.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Ginkgo Bioworks Holdings Inc’s return on equity (ROE) stands at -0.64.